Inventor · disambiguated record
Xin Cheng
Also filed as: CHENG XIN · CHENG XIN HUA
11 granted patents·8 pending applications·94 citations·filing 2005–2024
87Inventor score
Files withINSILICO MEDICINE IP LTD7EISAI R&D MAN CO LTD4UNIV PENNSYLVANIA3CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE CHINESE ACAD OF SCIENCES2GREENE MARK I1
Top patents by PatentIndex Score
19 records- 0194US8765810B2Tumor necrosis factor inhibitorsUNIV PENNSYLVANIA·Filed 2012·Granted Jul 1, 2014·46 cites·12 claims
- 0292US10322192B2Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2018·Granted Jun 18, 2019·18 cites·11 claims
- 0391US11834440B2Beta-lactam derivatives for the treatment of diseasesINSILICO MEDICINE IP LTD·Filed 2023·Granted Dec 5, 2023·2 cites·30 claims
- 0490US9476030B2Self-renewing endodermal progenitor lines generated from human pluripotent stem cells and methods of use thereofTHE CHILDREN'S HOSPITAL OF PHILADELPHIA·Filed 2013·Granted Oct 25, 2016·19 cites·7 claims
- 0588US10548986B2Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2017·Granted Feb 4, 2020·9 cites·13 claims
- 0679US12091406B2Lysine acetyltransferase 6A (KAT6A) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Sep 17, 2024·0 cites·20 claims
- 0778US12162862B2Beta-lactam derivatives for the treatment of diseasesINSILICO MEDICINE IP LTD·Filed 2023·Granted Dec 10, 2024·0 cites·25 claims
- 0878US2025163031A1Beta-lactam derivatives for the treatment of diseasesINSILICO MEDICINE IP LTD·Filed 2024·Application pending·0 cites
- 0976US2023398228A1Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 1073US2024109880A1Lysine acetyltransferase 6a (kat6a) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1172US2020297860A1Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2019·Application pending·0 cites
- 1260US9096607B2Tumor necrosis factor inhibitorsUNIV PENNSYLVANIA·Filed 2014·Granted Aug 4, 2015·0 cites·15 claims
- 1357US8318699B2Tumor necrosis factor inhibitorsGREENE MARK I·Filed 2006·Granted Nov 27, 2012·0 cites·4 claims
- 1455US2025101019A1Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1555US2024336611A1Analogs for the treatment of diseaseINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 1650US9909106B2Recombinant baculovirus expression vector and cellUNIV MIAMI·Filed 2014·Granted Mar 6, 2018·0 cites·6 claims
- 1749US7842456B2Reagents, kits and methods for immunodetection of epitopes on moleculesUNIV PENNSYLVANIA·Filed 2005·Granted Nov 30, 2010·0 cites·6 claims
- 1849US2023365925A1Method for Inducing Differentiated Cells Into Pluripotent Endoderm Stem Cells and Application ThereofCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE CHINESE ACAD OF SCIENCES·Filed 2020·Application pending·0 cites
- 1948US2023043161A1Application of cst1 in prevention and/or treatment of liver immune dysregulation diseasesCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE CHINESE ACAD OF SCIENCES·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xin Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →